Ban Bio-Tech Regulators' Use of New Drugs

     As pharmaceutical stocks plummeted, Monday, due largely to the disposition of bio-tech regulators, I think that those bureaucrats should be forced to personally face the implications of the philosophy they are promoting.

As things stand now, the pharmaceutical industry is running in a crippled state.  It is half-way destroyed--yet still trying to function in inventing, manufacturing, and selling new medicines.  So, here come these Democrat politicians and regulators trying to further destroy the businesses--which would eliminate drug innovation.

My argument is that anyone who pushes for control or destruction of pharmaceutical companies should be granted the end that one seeks--but against oneself, not us!  These purveyors of regulation should be banished by law from ever personally using any new medicine that manages to be invented from this day forth for the rest of one's life.  Furthermore, the regulators' family, children, grandchildren, great grandchildren, etc... must be banned from obtaining any of the new medicines, too.  The regulators seek to take away our future despite the fact that they will go down with us.  They are counting on our struggle to continue to innovate as a way to keep alive for one generation longer.  I say: "Let them perish without us."

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)

Objectivists Bury Neoconservatism

     I chose to read Neoconservatism: An Obituary for an Idea by the Objectivists: C. Bradley Thompson and Yaron Brook to see if it would help me to reflect upon the Republican contenders campaigning to become the nominee for President.  The book is an in-depth commentary on the history and philosophic intricacies of neoconservatives--such as Pat Buchanan and John McCain which the book mentions by name.  I identify Jeb Bush as fitting much of the neoconservative persuasion.  The final chapter draws some enlightening conclusions about their nature:

"Politically, the neocons combine the worst vices of both liberalism and conservatism.  Whereas American conservatives want to regulate man's spiritual or moral concerns (e.g., abortion, pornography, drugs, education) and liberals want to regulate man's material concerns (e.g., property, production, trade), the neocons want to regulate both--but moderately so."(pgs. 241-242)

"The neocons are, we fear, laying the groundwork for a new kind of soft despotism that will surely pave the way one day for despotism of the hard variety."(pg. 242)

The book explains that author C. Bradley Thompson lived for many years in a neoconservative environment--until he finally broke ranks.  Personally, I wrote a lot of blogs that had the neoconservative philosophy significantly present back when I first began blogging about international events in 2005.  This book has really helped me reform my philosophy to respect American values such as private property even in a time that threatens to break out into war.  While it is true that a country must have a military for protection, and, I understand too well the truth of "peace through strength", to: build up American forces, project power, and maneuver all over the globe, but never actually achieve a decisive end, is not only pointless, strategically, it destroys trillions of dollars worth of individual Americans' private property.

Neoconservatism; An Obituary for an Idea can be purchased at The Ayn Rand Institute eStore.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)

How to lose Indiana

     With presidential primary season approaching, those politicians who seek a chance at obtaining the highest executive office in the United States of America may want to examine their strategy as far as it relates to what the residents in the various individual states want.  Having suffered so much economically, Americans value the prospect of higher pay, and for many the existence of any job at all, above a politician's personal socialist philosophy.

Take Indiana, for instance.  The politician who wins that state will gain 11 electoral votes.  So, what should one's strategy be?  Begin by examining the economic and philosophical landscape.

The biggest corporation based in Indiana is pharmaceutical giant, Eli Lilly & Co. (LLY)--with a current market cap of about 98 billion dollars.  As a politician, is the wisest strategy to stick it to Lilly and/or the entire Big Pharma industry?  Would an Eli Lilly employee who sees this done forget about the absent Xmas bonus, or lost job that the research success which Eli Lilly & Co. was having had promised?  Are the economically secondary workers who trade with those who work for Eli Lilly unaware that what's good for Eli Lilly & Co. (LLY) is good for oneself?  What about those who trade with them?  Etc...

Indiana has made national news, recently, for another issue.  The state passed a bill that limited LGBT liberties.  However, one fact that is less well known is that Eli Lilly rallied against the RFRA and was instrumental in overturning it.

In summary, my argument in this blog is that if a politician is going to win the votes of a state, one should turn one's attention to the biggest businesses that reside where one is campaigning.  And, if one wants to lose, destroy: the jobs, individual liberty, and finally the votes that could have been cast with one's name on them.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)

Crawl because Hillary requires it.

     Yesterday, Hillary attacked the pharmaceutical industry--a business sector of which I am a defender.  In the style of Donald Trump, who has taught Americans to fight back when attacked, I respond with a poem that I wrote about 8 years ago when it looked like Hillary was going to be the sponsor of ObamaCare:


Crawl because Hillary requires it.
-by Paul Wharton

Hillary's socialized medicine
is passed in America the free.
Clinton knows what power can begin-
the lines of people begging from she.

Hillary is a fortunate femme.
So few resist the taxes and laws.
Money gushes into the system,
and, blood out through forced needle lab draws.

But, the Hillary cost crunch does start.
Some citizens must be turned away.
A man pleads without a bleeding heart,
but dies, nevertheless, the next day.

Hillary faces a budget debt.
There is not much cash to go around.
Does she punish the source of a threat,
or, fund a coaxing, groveling sound?

To pick and choose has been her life's dream-
of those she likes to heal by permit.
The delight this fuels is a sharp scream.
Crawl because Hillary requires it!


Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)

Lilly Keeps Rising

     I bought the 100 shares of Eli Lilly & Co. (LLY) I own on 7/23/13.  Since that time, the value of my stock has gone up 76.99%.  In fact, yesterday alone, (LLY) appreciated 6.55%.  This is especially significant, as it was a down day for the Dow Jones Industrial Average.

You may point to other companies that are doing as well or better.  But, considering that Eli Lilly (LLY) is a Large Cap business with all of the low-risk stability which goes along with that, I'd say (LLY) stockholders are pretty smart.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)

Eli Lilly Takes on Parkinson's

     I wrote a really good article on 9/20/13 at my previous blog: Lilly Fuel.  Its title is The Greatest Gamble.

In that post I explain that investing in the pharmaceutical business can not only earn oneself profit, it can save one's own life!  My Grandmother died from Parkinson's disease.  Since there is some hereditary correlation, I have a significant chance of getting it at some point.

When I wrote The Greatest Gamble, I was already aware of Eli Lilly & Co.'s Parkinson's treatment that is a Florbenazine Imaging Agent (now in Phase II testing).  However, what has me really excited is the discovery of another anti-Parkinson's candidate that I just came across a few days ago (in Phase I testing).

I have no idea if Lilly's new molecule is actually protective against Parkinson's.  And, even so, to be legally sold it would have to make it past the FDA.  But, consider for a moment what it would mean if it is a cure.  While it would be true that the scientists and businessmen at Eli Lilly & Co. (LLY) would get half of the credit for the medical product, I, as an investor, intellectual, and advocate for Parkinson's research might be responsible for the other half.

One day, I may be able to boast that I'm living a few extra years longer due to my work.  And, maybe I'll also be able to claim the title of having done half the work in curing Parkinson's disease!  That would be a life achievement to put under my belt.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)

Current Projects

     As an intellectual sponsored by Eli Lilly & Co. (LLY), it is only just that I direct my work towards studying in ways and producing blogs that help the business which improves my mind with its medicine.  Therefore, I am undertaking two projects that are directed towards helping Lilly stock rise.

The first is reading a book that was sold by The Ayn Rand Institute eStore called Neoconservatism: An Obituary for an Idea.  This project is aimed at arming myself with a better understanding of certain immoral politicians in the Republican Party, such as Jeb Bush.

The second project is scientific in nature.  I plan to read a major part of a General Biology textbook.  It is the section on human and animal biology, the need of which involves an interesting story from my college years.

If I could have named the specific major I wanted in college it would have been Fisheries Ecology.  I had wanted to study that for many years in high school and in my youth.  While I had picked up some environmentalism in my formal and self-education, back then, before the discovery of Objectivism wiped it all out, that was not my goal.  I wanted to study natural freshwater systems.  I had no motivation to control the fisheries industry.

One day in college, I discovered a new computer game called, Railroad Tycoon.  It was an extremely addictive game.  I think I played it for 24 hours straight, and then went to bed--only to get back on my computer when I woke up.  I knew I should not be neglecting my studies--let alone be skipping class; but the game was just so good!

In my General Biology class, at this time, we were getting into human anatomy and physiology which didn't help.  I had no interest in going into anything medical after college--so I had about zero motivation to do the reading, or even to go to that class.  Well, after many transcontinental railroad crossings, I finally went to biology a week later to discover that all my friends thought I had dropped the class.  I not only missed taking notes; I didn't read a thing in the textbook.  It turned out that I failed the test on that section--giving me a grade in the "C" range in the base class closest to my major--which is really bad.

I was normally a very good student in high school and college--except for the college sophomore year when I put everything into the Crew Team.  But, that is a story for another blog.  The point of this one is that I am somewhat ignorant on human anatomy and physiology.  So, I am endeavoring to read about a 300 page textbook section in a General Biology book to try to gain the basic vocabulary and concepts.  This should help me to understand the language of medicine much better as I continue to read and blog for Eli Lilly & Co. (LLY).

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)